Please use this identifier to cite or link to this item:
http://hdl.handle.net/2440/38803
Type: | Journal article |
Title: | Guidelines for the management of postmenopausal osteoporosis for GPs |
Author: | O'Neill, S. MacLennan, A. Diamond, T. Ebeling, P. Findlay, D. Flicker, L. Markwell, A. Nowson, C. Pocock, N. Sambrook, P. Fiatarone-Singh, M. |
Citation: | Australian Family Physician, 2004; 33(11):910-919 |
Publisher: | Royal Australian College of General Practitioners |
Issue Date: | 2004 |
ISSN: | 0300-8495 |
Statement of Responsibility: | O'Neill S; MacLennan A; Bass S; Diamond T; Ebeling P; Findlay D; Flicker L; Markwell A; Nowson C; Pocock N; Sambrook P; Singh MF |
Abstract: | Background: Since the last series of guidelines on the management of osteoporosis from Osteoporosis Australia was published in Australian Family Physician (October 2002), there have been further advances in our understanding of the treatment involved in both the prevention of bone loss and the management of established osteoporosis. Objective: This article provides updated guidelines for the management of postmenopausal osteoporosis to assist general practitioners identify those women at risk, and reviews current treatment strategies. DISCUSSION: Osteoporosis and its associated problems are major health concerns in Australia, especially with an aging population. While important principles of management are still considered to be maximising peak bone mass and preventing postmenopausal bone loss, new clinical trial data about drugs such as the bisphosphonates, raloxifene and oestrogen have recently become available and the relative role of various agents is gradually becoming clearer. The use of long term hormone therapy has mixed risks and benefits that requires individual patient counselling. |
Keywords: | Osteoporosis Australia Medical Scientific Committee; Humans; Bone Diseases, Metabolic; Osteoporosis, Postmenopausal; Calcium; Organometallic Compounds; Diphosphonates; Thiophenes; Benzothiadiazines; Selective Estrogen Receptor Modulators; Parathyroid Hormone; Vitamin D; Antihypertensive Agents; Diuretics; Biological Markers; Absorptiometry, Photon; Drug Therapy, Combination; Estrogen Replacement Therapy; Risk Factors; Family Practice; Aged; Middle Aged; Female; Sodium Chloride Symporter Inhibitors; Fractures, Bone |
Description: | Copyright © 2004 Royal Australian College of General Practitioners Copyright to Australian Family Physician. Reproduced with permission. Permission to reproduce must be sought from the publisher, The Royal Australian College of General Practitioners. |
RMID: | 0020071639 |
Published version: | http://www.racgp.org.au/afp/200411/14287 |
Appears in Collections: | Orthopaedics and Trauma publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
hdl_38803.pdf | 164 kB | Publisher's PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.